Search

Your search keyword '"Singer, Eric A."' showing total 130 results
Start Over Author "Singer, Eric A." Journal journal of urology
130 results on '"Singer, Eric A."'

1. PD23-08 RETHINKING THE DEFINITION OF STAGE III IN ADRENOCORTICAL CARCINOMA: ASSESSING THE IMPACT OF CLINICAL LYMPH NODE POSITIVE DISEASE

Author

Lichtbroun, Benjamin J., primary, Gao, Helen, additional, Chua, Kevin, additional, Pfail, John L., additional, Patel, Hiren V., additional, Elsamra, Sammy, additional, Golombos, David, additional, Packiam, Vignesh T., additional, Singer, Eric A., additional, Jang, Thomas L., additional, Ghodoussipour, Saum, additional, and Srivastava, Arnav, additional

Published
2024
Full Text
View/download PDF

3. Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study.

Author

Jakobsson, Rasmus G., Nasic, Salmir, Bratt, Ola, Johansson, Martin E., Bergdahl, Anna Grenabo, Kronstedt, Shane, and Singer, Eric A.

Abstract

Purpose: Our purpose was to investigate the association between family history of renal cell carcinoma (RCC) and RCC risk. Materials and Methods: RCC cases diagnosed in Sweden between 2005 and 2014 and 10 matched controls were identified using the Renal Cell Cancer Database Sweden, with linkage to the Multigeneration Register and the Swedish Cancer Registry. The association between a family history of RCC and RCC was investigated, overall and by sex and age groups. Results: Among 9416 RCC cases, 294 (3.1%) had 1 or more parent or sibling (first-degree relative [FDR]) with RCC. Median age at diagnosis for cases with an affected FDR was 65 years (IQR 59-71) and 68 years (IQR 60-75) for all cases. The proportion of women was significantly higher among familial RCC compared to sporadic RCC (44.6% vs 38.5%, P = .035). RCC was twice as likely with 1 or more FDR with RCC (OR 1.9; CI 1.65-2.16). Stratified analysis showed an OR of 2.4 for women (CI 1.93-2.92) and 1.6 for men (CI 1.35-1.93). Two ormore FDRs was associated with a sixfold increased risk (95% CI 2.37-15.5). Familial RCC was strongly associated with bilateral and multifocal tumors (OR 5.5; CI 2.36-13.0, OR 3.5; CI 1.89-6.49). Conclusions: In this Swedish data set, 3.1% of RCC patients have 1 or more FDR diagnosed with RCC. There was no statistical difference in median age between sporadic RCC and familial RCC. Having 1 or more FDR with RCC approximately doubles the risk of RCC with a higher risk increase for women than for men. People with 2 FDRs with RCC constitute a small high-risk group that may benefit from screening. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. PD24-06 ASSESSMENT OF SURGICAL COMPLICATIONS IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA (MCCRCC) RECEIVING PERIOPERATIVE CABOZANTINIB AND NIVOLUMAB ON CYTO-KIK CLINICAL TRIAL

Author

Runcie, Karie, primary, Ornstein, Moshe, additional, Saraiya, Biren, additional, Krishnamurthi, Venkatesh, additional, Lee, Byron, additional, Anderson, Christopher, additional, DeCastro, Guarionex, additional, McKiernan, James, additional, Mayer, Tina, additional, Dallos, Matthew, additional, Stein, Mark, additional, and Singer, Eric, additional

Published
2023
Full Text
View/download PDF

5. LBA03-08 PEMBROLIZUMAB (PEMBRO) FOR PATIENTS (PTS) WITH HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (HR NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG): EFFICACY AND EVALUATION OF SUBSEQUENT CYSTECTOMY FROM COHORT B OF THE PHASE 2 KEYNOTE-057 STUDY

Author

Singer, Eric, primary, Necchi, Andrea, additional, Roumiguié, Mathieu, additional, Esen, Ahmet Adil, additional, Lebret, Thierry, additional, de Wit, Ronald, additional, Bajorin, Dean F., additional, Krieger, Laurence E. M., additional, Kandori, Shuya, additional, Uchio, Edward M., additional, Seo, Ho Kyung, additional, Boormans, Joost, additional, Kamat, Ashish M., additional, Grivas, Petros, additional, Nishiyama, Hiroyuki, additional, Baranwal, Pranshu, additional, Kapadia, Ekta, additional, Van den Sigtenhorst-Fijlstra, Margot, additional, Kulkarni, Girish S., additional, and Shore, Neal D., additional

Published
2023
Full Text
View/download PDF

6. PD24-02 IMPACT OF SYSTEMIC THERAPY (ST) ON DEFERRED CYTOREDUCTIVE NEPHRECTOMY (CN) PERIOPERATIVE OUTCOMES: A NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) ANALYSIS

Author

Dason, Shawn, primary, Sheetz, Tyler, additional, Ray, Shagnik, additional, Zimmerman, Danielle, additional, Yin, Ming, additional, Folefac, Edmund, additional, Mortazavi, Amir, additional, Gong, Michael, additional, Shabsigh, Ahmad, additional, Posid, Tasha, additional, and Singer, Eric, additional

Published
2023
Full Text
View/download PDF

7. MP63-05 OUTCOMES IN PATIENTS (PTS) WITH BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE HIGH-RISK (HR) NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) WHO UNDERWENT RADICAL CYSTECTOMY (RC) FOLLOWING PEMBROLIZUMAB (PEMBRO) TREATMENT IN KEYNOTE-057 COHORT A

Author

Kulkarni, Girish S., primary, Kamat, Ashish M., additional, Uchio, Edward M., additional, Roumiguié, Mathieu, additional, Krieger, Laurence E. M., additional, Singer, Eric A., additional, Bajorin, Dean F., additional, Grivas, Petros, additional, Seo, Ho Kyung, additional, Nishiyama, Hiroyuki, additional, Konety, Badrinath R., additional, Wit, Ronald de, additional, Kapadia, Ekta, additional, Xing, Aiwen, additional, Fijlstra, Margot Van den Sigtenhorst, additional, and Boormans, Joost L., additional

Published
2023
Full Text
View/download PDF

10. MP03-20 CONTEMPORARY ANALYSIS OF CYSTECTOMY COMPLICATIONS

Author

Chua, Kevin, primary, Patel, Hiren, additional, Srivastava, Arnav, additional, Doppalapudi, Sai Krishnaraya, additional, Lichtbroun, Benjamin, additional, Elsamra, Sammy, additional, Singer, Eric, additional, Jang, Thomas, additional, and Ghodoussipour, Saum, additional

Published
2022
Full Text
View/download PDF

11. PD41-03 ANTIBIOTIC-FREE TRANSPERINEAL PROSTATE BIOPSY: UROLOGY’S CONTRIBUTION TO RESPONSIBLE ANTIMICROBIAL STEWARDSHIP

Author

Ginsburg, Kevin B., primary, Drevik, Johnathan, additional, Schober, Jared P., additional, Castro Bigalli, Alberto A., additional, Ellis, Jeffrey L., additional, Braun, Avery, additional, Syed, Kaynaat, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Reese, Adam C., additional, Tomaszewski, Jeffrey, additional, Trabulsi, Edouard, additional, Singer, Eric A., additional, Jacobs, Bruce, additional, Raman, Jay D., additional, Guzzo, Thomas, additional, Uzzo, Robert G., additional, Smaldone, Marc C., additional, and Correa, Andres F., additional

Published
2022
Full Text
View/download PDF

12. MP43-16 RACIAL DISPARITIES IN RATES OF GLEASON GRADE RECLASSIFICATION IN A MULTI-INSTITUTIONAL PROSTATE CANCER ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS

Author

Reddy, Rohit, primary, Strauss, David, additional, Loecher, Matthew, additional, Syed, Kaynaat, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Tomaszewski, Jeffrey, additional, Trabulsi, Edouard, additional, Singer, Eric A., additional, Jacobs, Bruce L., additional, Raman, Jay, additional, Guzzo, Thomas, additional, Uzzo, Robert, additional, and Reese, Adam C., additional

Published
2022
Full Text
View/download PDF

14. PD41-10 THE UTILITY OF PSA DENSITY IN PATIENTS WITH PI-RADS 3 LESIONS ACROSS A LARGE MULTI-INSTITUTIONAL COLLABORATIVE

Author

Drevik, Johnathan, primary, Dalimov, Zafardjan, additional, Syed, Kaynaat, additional, Danella, John, additional, Belkoff, Laurence, additional, Reese, Adam, additional, Tomaszewski, Jeffrey, additional, Trabulsi, Edouard, additional, Singer, Eric, additional, Jacobs, Bruce, additional, Raman, Jay, additional, Guzzo, Thomas, additional, Correa, Andres, additional, Smaldone, Marc, additional, Uzzo, Robert, additional, and Ginzburg, Serge, additional

Published
2022
Full Text
View/download PDF

16. MP43-06 COMPARING MRI/US FUSION TO STANDARD PROSTATE BIOPSY IN DETERMINING GRADE RECLASSIFICATION AT CONFIRMATORY BIOPSY IN A MULTI-INSTITUTIONAL ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS

Author

Strauss, David, primary, Reddy, Rohit, additional, Loecher, Matthew, additional, Syed, Kaynaat, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Tomaszewski, Jeffrey, additional, Trabulsi, Edouard, additional, Singer, Eric, additional, Jacobs, Bruce, additional, Raman, Jay, additional, Guzzo, Thomas, additional, Uzzo, Robert, additional, and Reese, Adam, additional

Published
2022
Full Text
View/download PDF

17. Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer

Author

Patel, Hiren V., primary, Srivastava, Arnav, additional, Kim, Sinae, additional, Patel, Hiten D., additional, Pierorazio, Phillip M., additional, Bagrodia, Aditya, additional, Masterson, Timothy A., additional, Ghodoussipour, Saum B., additional, Kim, Isaac Y., additional, Singer, Eric A., additional, and Jang, Thomas L., additional

Published
2022
Full Text
View/download PDF

18. PD41-05 BIOPSY TECHNIQUE (TRANSPERINEAL VS. TRANSRECTAL) IS NOT ASSOCIATED WITH POSITIVE SURGICAL MARGINS OR PERIOPERATIVE MORBIDITY FOLLOWING RADICAL PROSTATECTOMY

Author

Ginsburg, Kevin, primary, Drevik, Johnathan, additional, Castro Bigalli, Alberto Andres, additional, Ellis, Jeffrey, additional, Braun, Avery, additional, Syed, Kaynaat, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Reese, Adam, additional, Tomaszewski, Jeffrey, additional, Trabulsi, Edouard, additional, Singer, Eric, additional, Jacobs, Bruce, additional, Raman, Jay, additional, Guzzo, Thomas, additional, Uzzo, Robert, additional, Smaldone, Marc, additional, and Correa, Andres, additional

Published
2022
Full Text
View/download PDF

19. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study).

Author

Lannes, François, Baboudjian, Michael, Ruffion, Alain, Rouy, Mathieu, Giammarile, Francesco, Rousseau, Thierry, Kraeber-Bodéré, Françoise, Rousseau, Caroline, Rusu, Daniela, Colombié, Mathilde, Brenot-Rossi, Isabelle, Rossi, Dominique, Mottet, Nicolas, Bastide, Cyrille, Faiena, Izak, and Singer, Eric A.

Subjects
SENTINEL lymph node biopsy, SENTINEL lymph nodes, LYMPH nodes, PROSTATE cancer, LYMPHADENECTOMY
Abstract

Purpose: Our aim was to prospectively evaluate the diagnostic accuracy of sentinel lymph node biopsy-guided lymph node dissection compared to extended pelvic lymph node dissection in patients with intermediate- or high-risk prostate cancer. Materials and Methods: We conducted a prospective, single-arm, multicenter study at 3 tertiary centers in France between February 2012 and May 2019. Eligible patients had clinically localized intermediate- or high-risk prostate cancer. After intraprostatic injection of (99m)Tc-nanocolloid, the locations of the sentinel lymph nodes were defined by preoperative lymphoscintigraphy. Surgical excision of the sentinel lymph nodes was performed using intraoperative gamma probe guidance. After resection of the sentinel lymph nodes, extended pelvic lymph node dissection was performed in all patients. We assessed the diagnostic accuracy of the sentinel lymph node biopsy method using extended pelvic lymph node dissection as the reference standard. This trial was registered in ClinicalTrials.gov (NCT02732392). Results: A total of 162 men cN0M0 (CT scan and bone scan) were enrolled: 106 (65.4%) and 56 (34.6%) patients had intermediate- and high-risk prostate cancer, respectively. The median number of nodes retrieved was 14 (mean 16, IQR 10-21) per patient. At final pathological analysis, 22 patients (13.6%) were pN+. Sensitivity, specificity, negative predictive value, and positive predictive value of sentinel lymph node biopsy method in detecting patients with at least 1 lymph node metastasis were 95.4% (95% CI, 75.1-99.7), 100% (95% CI, 96.6-100), 99.2% (95% CI, 95.5-99.9), and 100% (95% CI, 80.7-100), respectively. Conclusions: Our multicenter prospective study supports that sentinel lymph node biopsy is a very effective and sensitive method for pelvic lymph node staging in patients with intermediate- or high-risk localized prostate cancer. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

22. PD03-02 RACIAL DISPARITIES IN PROSTATE CANCER TREATMENT IN A MULTI-INSTITUTIONAL REGIONAL COLLABORATIVE

Author

Bernstein, Adrien, primary, Talwar, Ruchika, additional, Handorf, Elizabeth, additional, Syed, Kaynaat, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Reese, Adam, additional, Tomaszewski, Jeffery, additional, Singer, Eric, additional, Trabulsi, Edouard, additional, Jacobs, Bruce, additional, Raman, Jay, additional, Kutikov, Alex, additional, Guzzo, Thomas, additional, Uzzo, Robert, additional, Smaldone, Marc, additional, and Correa, Andres, additional

Published
2021
Full Text
View/download PDF

23. MP45-16 THE IMPACT OF VENOUS THROMBOEMBOLISM PRESENCE AT THE TIME OF NEPHRECTOMY FOR RENAL MASS ON COMPLICATIONS, COSTS, AND SURVIVAL

Author

Patel, Hiren, primary, Sterling, Joshua, additional, Srivastava, Arnav, additional, Shinder, Brian, additional, Grandhi, Miral, additional, August, David, additional, Rahimi, Saum, additional, Kim, Isaac, additional, Ghodoussipour, Saum, additional, Jang, Thomas, additional, Chung, Benjamin, additional, Chang, Steven, additional, and Singer, Eric, additional

Published
2021
Full Text
View/download PDF

24. PD56-12 UTILIZATION OF MRI AND GENOMIC TESTS IN MEN WITH LOW-RISK PROSTATE CANCER AND A LIMITED LIFE EXPECTANCY WITHIN A MULTI-INSTITUTIONAL REGIONAL COLLABORATIVE

Author

Kidd, Laura, primary, Bernstein, Adrien, additional, Ginsburg, Kevin, additional, Handorf, Elizabeth, additional, Syed, Kaynaat, additional, Mehta, Chintan, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Reese, Adam, additional, Tomaszewski, Jeffrey, additional, Singer, Eric, additional, Trabulsi, Edouard, additional, Jacobs, Bruce, additional, Raman, Jay, additional, Guzzo, Thomas, additional, and Smaldone, Marc, additional

Published
2021
Full Text
View/download PDF

27. MP05-04 CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATES ON MRI GUIDED FUSION NEEDLE BIOPSY - EXPERIENCE FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE

Author

Ako, Ako Adams, primary, Ginzburg, Serge, additional, Singer, Eric, additional, Jacobs, Bruce, additional, Fonshell, Claudette, additional, Reese, Adam, additional, Trabulsi, Edouard, additional, Tomaszewski, Jeffery, additional, Danella, John, additional, Belkoff, Laurence, additional, Guzzo, Thomas, additional, Uzzo, Robert, additional, and Raman, Jay, additional

Published
2021
Full Text
View/download PDF

29. MP43-16 CREATION AND VALIDATION OF PURC ACTIVE SURVEILLANCE ELIGIBILITY (PURCASE) SCORE: AN EMPIRICALLY DERIVED SCORING SYSTEM FOR DETERMINING ACTIVE SURVEILLANCE ELIGIBILITY

Author

Mehta, Chintan, primary, Rutledge, Cameron, additional, Loecher, Matthew, additional, Syed, Kaynaat, additional, Danella, John, additional, Ginzburg, Serge, additional, Belkoff, Laurence, additional, Tomaszewski, Jeffery, additional, Trabulsi, Edouard, additional, Singer, Eric, additional, Jacobs, Bruce, additional, Raman, Jay, additional, Guzzo, Thomas, additional, Uzzo, Robert, additional, and Reese, Adam, additional

Published
2021
Full Text
View/download PDF

31. PD53-11 RISK STRATIFICATION IN ADVANCED NON-SEMINOMATOUS GERM CELL TUMORS (NSGCT): VALIDATION OF AGE AND METASTATIC DISEASE SITE TO IMPROVE THE TRADITIONAL IGCCCG RISK GROUPS

Author

Srivastava, Arnav, primary, Patel, Hiren, additional, Cheaib, Joseph, additional, Singla, Nirmish, additional, Woldu, Solomon, additional, Quek, Marcus, additional, Gupta, Gopal, additional, Kim, Isaac, additional, Singer, Eric, additional, Jang, Thomas, additional, Pierorazio, Phillip, additional, Bagrodia, Aditya, additional, and Patel, Hiten, additional

Published
2021
Full Text
View/download PDF

32. MP16-14 CLINICAL OUTCOMES OF A RANDOMIZED, PROSPECTIVE, PHASE II STUDY TO DETERMINE THE EFFICACY OF BACILLUS CALMETTE-GUERIN (BCG) GIVEN IN COMBINATION WITH PANVAC VERSUS BCG GIVEN ALONE IN ADULTS WITH HIGH GRADE BCG-REFRACTORY NON-MUSCLE INVASIVE BLADDER CANCER

Author

Saoud, Ragheed, primary, Telfer, Siobhan, additional, Maruf, Mahir, additional, Singer, Eric, additional, Weiss, Robert, additional, Jang, Thomas, additional, Elsamra, Sammy, additional, Marino, Maria, additional, Valera, Vladimir, additional, Rodriguez, Beatriz Walter, additional, Railkar, Reema, additional, Dolan, Rebecca, additional, Bellfield, Sonia, additional, Stamatakis, Lambros, additional, Shih, Joanna, additional, Brancato, Sam, additional, Donohue, Renee, additional, Navarro, Cesar Pico, additional, Apolo, Andrea, additional, Gulley, James, additional, Schlom, Jeffrey, additional, and Agarwal, Piyush, additional

Published
2021
Full Text
View/download PDF

35. Quantifying Publication Rates and Time to Publication for American Urological Association Podium Presentations.

Author

Chua, Kevin J., Mikhail, Mark, Patel, Hiren V., Tabakin, Alexandra L., Doppalapudi, Sai Krishnaraya, Ghodoussipour, Saum B., Kim, Isaac Y., Jang, Thomas L., Srivastava, Arnav, and Singer, Eric A.

Subjects
CONFERENCE attendance, LOGISTIC regression analysis, ANNUAL meetings, SOCIAL media, STATISTICS
Abstract

Purpose: The American Urological Association (AUA) Annual Meeting serves as the premier platform for presenting unpublished research in urology. Among selected abstracts, podium presentations represent the most impactful submissions. While podium presentations receive a large audience through conference attendance and social media posts, it is unclear how often they manifest as publications in peer-reviewed journals. Materials and methods: Podium presentations from the 2017 AUA Annual Meeting were reviewed. Abstracts were assessed for publication between January 1, 2015 and May 31, 2020 allowing for a 3-year window of publication and accounting for publications prior to the submission deadline. Abstract authors were individually searched with key terms being added sequentially until <30 results were generated in PubMed®. Abstracts were deemed published if at least 1 author and 1 conclusion matched a manuscript. Publication rate, time to publication, and 2019 journal impact factor were collected. Statistical analysis was performed by linear and logistic regression. Results: Of 872 podium presentations, 453 (51.9%) were published within 3 years. Median time from submission to publication was 12.5 months (IQR: 7.5-20.5). The number of articles published at 1, 2 and 3 years from submission was 203, 368 and 430, respectively. The median journal impact factor of publications was 3.2 (IQR: 2.0-5.8). Oncology studies (OR=1.21 [95% CI: 0.91-1.60], p=0.186) had similar rates of publication compared to non-oncology studies. Conclusions: While AUA podium presentations disseminate valuable data, approximately half were not published in peer-reviewed journals within 3 years. Therefore, care must be taken when promoting findings or adopting new practices based on these presentations alone. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

36. MP20-07 CONCORDANCE BETWEEN MRI FUSION VS TRUS PROSTATE BIOPSY AND FINAL PATHOLOGY AT RADICAL PROSTATECTOMY: DATA FROM THE PURC

Author

Talwar*, Ruchika, primary, Michel, Katharine, additional, Malhotra, Aseem, additional, Marlowe, Bret, additional, Fonshell, Claudette, additional, Danella, John, additional, Ginzberg, Serge, additional, Jacobs, Bruce, additional, Lanchoney, Thomas, additional, Raman, Jay, additional, Singer, Eric, additional, Smaldone, Marc, additional, Tomaszewski, Jeffrey, additional, Trabulsi, Edouard, additional, Uzzo, Robert, additional, Lee, Daniel, additional, and Guzzo, Thomas, additional

Published
2020
Full Text
View/download PDF

39. MP14-20 IMPACT OF PATHOLOGIC NODE POSITIVE RENAL CELL CARCINOMA ON SURVIVAL IN PATIENTS WITHOUT METASTASIS: EVIDENCE IN SUPPORT OF EXPANDING THE DEFINITION OF STAGE IV KIDNEY CANCER

Author

Srivastava*, Arnav, primary, Rivera-Nunez, Zorimar, additional, Kim, Sinae, additional, Sterling, Joshua, additional, Farber, Nicholas, additional, Radadia, Kushan, additional, Modi, Parth, additional, Goyal, Sharad, additional, Parikh, Rahul, additional, Mayer, Tina, additional, Saraiya, Biren, additional, Weiss, Robert, additional, Kim, Isaac, additional, Elsamra, Sammy, additional, Jang, Thomas, additional, and Singer, Eric, additional

Published
2019
Full Text
View/download PDF

40. MP43-01 PHASE 2 KEYNOTE-057 STUDY: PEMBROLIZUMAB FOR PATIENTS WITH HIGH-RISK NON–MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN

Author

Kulkarini*, Girish S., primary, de Wit, Ronald, additional, Balar, Arjun V., additional, Kamat, Ashish, additional, Uchio, Edward, additional, Mourey, Loic, additional, Krieger, Laurence, additional, Singer, Eric A., additional, Bajorin, Dean, additional, Grivas, Petros, additional, Seo, Ho Kyung, additional, Nishiyama, Hiroyuku, additional, Konety, Badarinath, additional, Nam, Kijoeng, additional, Kapadia, Ekta, additional, Frenkl, Tara, additional, and Boormans, Joost L., additional

Published
2019
Full Text
View/download PDF

44. MP84-12 OUTCOMES AND FACTORS ASSOCIATED WITH RECEIPT OF OPEN VS MINIMALLY INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR TESTIS CANCER: ANALYZING THE NATIONAL CANCER DATABASE (NCDB) FROM 2010-2014

Author

Tabakin, Alexandra L., primary, Kim, Sinae, additional, Polotti, Charles F., additional, Rivera-Núñez, Zorimar, additional, Sterling, Joshua, additional, Modi, Parth K., additional, Farber, Nicholas J., additional, Radadia, Kushan D., additional, Parikh, Rahul, additional, Goyal, Sharad, additional, Weiss, Robert E., additional, Kim, Isaac Y., additional, Elsamra, Sammy E., additional, Singer, Eric A., additional, and Jang, Thomas L., additional

Published
2018
Full Text
View/download PDF

46. MP60-08 INTRACRINE ANDROGEN BIOSYNTHESIS IN RENAL CELL CARCINOMA

Author

Lee, Geun Taek, primary, Han, Christopher, additional, Kwon, Young Suk, additional, Patel, Rutveej, additional, Modi, Parth, additional, Kwon, Seok Joo, additional, Faiena, Izak, additional, Patel, Neal, additional, Ahn, Han-Jong, additional, Kim, Wun-Jae, additional, Singer, Eric, additional, and Kim, Isaac, additional

Published
2017
Full Text
View/download PDF

47. MP15-10 IMMUNOLOGIC RESPONSE TO A THERAPEUTIC CANCER VACCINE (PANVAC): INITIAL RESULTS FROM A RANDOMIZED PHASE 2 CLINICAL TRIAL

Author

Sanford, Thomas, primary, Donahue, Renee, additional, Jochems, Caroline, additional, Dolan, Rebecca, additional, Bellfield, Sonia, additional, Anderson, Megan, additional, Singer, Eric, additional, Weiss, Robert, additional, Elsamra, Sammy, additional, Jang, Thomas, additional, Brancato, Sam, additional, Su, Daniel, additional, Wall, Yvonne, additional, Gulley, James, additional, Schlom, Jeffrey, additional, and Agarwal, Piyush, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results